I think Mr. Murphy has made an over statement of the facts. The CEO has guided investors for the past year or so, Amarin expects the trial to go to completion. Mr. Murphy has simply echoed this guidance and made an overstatement likely to poke fun at the brains of the board, who have foolishly predicted in all likelihood the trial will be stopped.
The FDA has 100% not followed the appropriate regulation and guidance for the industry when they convened an unlawful Ad Com then use this advisory vote, as supporting significant science to rescind ANCHOR SPA. There's no 70-75% chance this happened....it's 100%.
It's unwise for a "respected" member of the board to attempt to qualify and quantify a factual statement with odds ratios. Mr. Murphy has been emotionally abused by this board. He regrets his misstatements, so drop it.
BB
News 
Market Data 
Discover 
AI
